Los Angeles Capital Management LLC purchased a new stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) in the first quarter, according to its most recent filing with the SEC. The fund purchased 1,769,056 shares of the pharmacy operator's stock, valued at approximately $19,760,000. Los Angeles Capital Management LLC owned about 0.20% of Walgreens Boots Alliance at the end of the most recent quarter.
Other institutional investors have also made changes to their positions in the company. Colonial Trust Co SC grew its stake in Walgreens Boots Alliance by 79.5% during the 4th quarter. Colonial Trust Co SC now owns 2,928 shares of the pharmacy operator's stock worth $27,000 after buying an additional 1,297 shares during the last quarter. Sentry Investment Management LLC bought a new position in Walgreens Boots Alliance during the 1st quarter worth $27,000. Curat Global LLC bought a new position in Walgreens Boots Alliance during the 1st quarter worth $27,000. Central Pacific Bank Trust Division grew its stake in Walgreens Boots Alliance by 28.6% during the 1st quarter. Central Pacific Bank Trust Division now owns 4,500 shares of the pharmacy operator's stock worth $50,000 after buying an additional 1,000 shares during the last quarter. Finally, Strategic Investment Solutions Inc. IL grew its stake in Walgreens Boots Alliance by 133.6% during the 4th quarter. Strategic Investment Solutions Inc. IL now owns 6,100 shares of the pharmacy operator's stock worth $57,000 after buying an additional 3,489 shares during the last quarter. 58.59% of the stock is currently owned by institutional investors.
Insider Activity at Walgreens Boots Alliance
In related news, Chairman Stefano Pessina bought 832,258 shares of Walgreens Boots Alliance stock in a transaction dated Sunday, April 27th. The stock was acquired at an average cost of $11.01 per share, with a total value of $9,163,160.58. Following the completion of the acquisition, the chairman directly owned 145,621,079 shares in the company, valued at approximately $1,603,288,079.79. This trade represents a 0.57% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 17.50% of the stock is currently owned by corporate insiders.
Wall Street Analyst Weigh In
A number of brokerages recently commented on WBA. Morgan Stanley restated an "underweight" rating on shares of Walgreens Boots Alliance in a research note on Thursday, June 26th. Wall Street Zen initiated coverage on Walgreens Boots Alliance in a research report on Wednesday, May 21st. They set a "hold" rating for the company. Finally, UBS Group reiterated a "neutral" rating on shares of Walgreens Boots Alliance in a research report on Thursday, June 26th. Four investment analysts have rated the stock with a sell rating, seven have given a hold rating and two have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Walgreens Boots Alliance currently has an average rating of "Hold" and an average target price of $10.59.
Read Our Latest Stock Report on WBA
Walgreens Boots Alliance Price Performance
Shares of Walgreens Boots Alliance stock traded up $0.07 during trading on Thursday, hitting $11.60. The stock had a trading volume of 2,735,648 shares, compared to its average volume of 16,568,957. The company has a debt-to-equity ratio of 0.96, a current ratio of 0.60 and a quick ratio of 0.32. The firm has a market cap of $10.04 billion, a P/E ratio of -1.59, a PEG ratio of 1.35 and a beta of 0.78. The business has a fifty day moving average of $11.37 and a two-hundred day moving average of $11.07. Walgreens Boots Alliance, Inc. has a fifty-two week low of $8.08 and a fifty-two week high of $13.25.
Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last announced its earnings results on Thursday, June 26th. The pharmacy operator reported $0.38 EPS for the quarter, beating the consensus estimate of $0.34 by $0.04. Walgreens Boots Alliance had a positive return on equity of 17.66% and a negative net margin of 4.07%. The business had revenue of $38.99 billion during the quarter, compared to the consensus estimate of $36.72 billion. During the same period in the prior year, the business posted $0.63 earnings per share. Walgreens Boots Alliance's revenue was up 7.2% compared to the same quarter last year. On average, sell-side analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.
Walgreens Boots Alliance Company Profile
(
Free Report)
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
Further Reading
Before you consider Walgreens Boots Alliance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Walgreens Boots Alliance wasn't on the list.
While Walgreens Boots Alliance currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access